logo
15:59 Jan 28

Syngene International Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
480.30
-9.40 (-1.92%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syngene International Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
480.30
-9.40 (-1.92%)
15:59 Jan 28
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

30/100
Technically Bearish

Strength

6

Weakness

10

Opportunity

0

Threats

0

10.49 %

ROE %

7.30 %

ROA %

8.74

EPS

117.44

BVPS

13.62 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
2184.3 2604.2 3192.9 3488.6 3642.4
Operating Expenses +
1512.5 1808.1 2258.5 2474.2 2600.6
Raw Material
551.7 770.6 902.2 873.6 925.4
Increase Decrease in Cost
-25.2 -21.6 -42 56.6 17.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
660.2 718.1 841.7 888.7 983.9
Miscellaneous Expenses
325.8 341 556.6 655.3 674.2
Operating Profit
671.8 796.1 934.4 1014.4 1041.8
Other Income
64.6 52.8 70.9 90.6 71.8
Depreciation
274.5 309.7 366.5 425.9 432.6
Interest
27.7 24.1 45.2 47.2 53.1
Profit before tax and exceptio..
434.2 515.1 593.6 631.9 627.9
Exceptional Items
35 -30.7 0 -11.1 32
PBT
469.2 484.4 593.6 620.8 659.9
Provision for Taxation
64.3 88.6 129.2 110.8 163.7
Net Profit
404.9 395.8 464.4 510 496.2
NET Profit after MI
404.9 395.8 464.4 510 496.2
EPS
10.11 9.82 11.51 12.69 12.34
Operating Profit Margin (%)
30.76 30.57 29.26 29.08 28.6
Net Profit Margin (%)
18.54 15.2 14.54 14.62 13.62

Syngene International Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 52.70 52.70 52.70 52.70 52.70 54.70
FII 15.00 16.30 16.50 19.50 20.60 20.70
Public 25.80 24.60 24.10 21.50 19.60 17.50
Others 6.50 6.40 6.70 6.30 7.10 7.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: